Skip to search formSkip to main contentSkip to account menu

iodine I 123 monoclonal antibody 81C6

Known as: 81C6, I 123 Monoclonal Antibody 81C6, iodine I 123 MOAB 81C6 
A radioimmunoconjugate of a IgG2 monoclonal antibody (MoAb) 81C6 labeled with iodine 123 (I-123). MoAb 81C6 recognizes the extracellular matrix… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
UNLABELLED The objective of this study was to perform the dosimetry of 131I-labeled 81C6 monoclonal antibody (MAb) in patients… 
Highly Cited
1993
Highly Cited
1993
RATIONALE AND OBJECTIVES Monoclonal antibody 81C6 reacts with the extracellular matrix antigen, tenascin, present on gliomas and… 
Highly Cited
1989
Highly Cited
1989
Loss of radiolabel after in vivo administration of labeled monoclonal antibodies (MAbs) to cancer patients is a likely cause of… 
Highly Cited
1988
Highly Cited
1988
Lack of tumor specificity renders current modalities for treating malignant glioma ineffective. The administration of 131I… 
1988
1988
The localisation of the radioiodinated Fab fragment of monoclonal antibody (Mab) 81C6, reactive with a glioma-associated… 
Highly Cited
1987
Highly Cited
1987
The distribution of type VI collagen was examined immunohistochemically in normal tissues and in 24 human gliomas and six… 
1987
1987
Monoclonal antibody 81C6, which is directed against a human gliomamesenchymal extracellular matrix antigen, was used to evaluate… 
1986
1986
Current diagnostic and therapeutic modalities for malignant human gliomas are largely nonspecific. The development of monoclonal… 
Highly Cited
1984
Highly Cited
1984
The murine antiglioma monoclonal antibody 81C6 has been shown to specifically localize in U-251 MG and D-54 MG human glioma…